| C.E.R.A. dose group (μg/kg QW) | C.E.R.A. dose group (μg/kg Q3W) | ||||
---|---|---|---|---|---|---|
 | 0.7 | 1.4 | 2.1 | 2.1 | 4.2 | 6.3 |
Number of patients randomized | 36 | 37 | 36 | 37 | 37 | 35 |
Number of patients in ITT/safety population* | 36 | 37 | 35 | 34 | 37 | 34 |
Number of patients in PP population | 22 | 23 | 20 | 21 | 27 | 25 |
Number of randomized patients excluded from PP population | 14 | 14 | 16 | 16 | 10 | 10 |
Reasons for exclusion from PP population** | Â | Â | Â | Â | Â | Â |
   Blood transfusion during study period | 13 | 12 | 14 | 16 | 7 | 5 |
   Acute infection/inflammatory disease (CRP > 50 mg/L) | 1 | 4 | 1 | 2 | 3 | 3 |
   Received no study medication | 0 | 0 | 1 | 3 | 0 | 1 |
   Blood transfusion during 4-week period before study entry | 0 | 0 | 0 | 3 | 0 | 0 |
   Inclusion criteria not met | 0 | 0 | 0 | 0 | 0 | 1 |